Cargando…
Parallel evolution of linezolid-resistant Staphylococcus aureus in patients with cystic fibrosis
Linezolid is an antibiotic used to treat serious Staphylococcus aureus infections. Resistance to linezolid is considered rare but could emerge with repeated dosing. We recently reported widespread prescription of linezolid for a cohort of patients with cystic fibrosis (CF). The goals of this study w...
Autores principales: | Pitcher, Nicholas J., Feder, Andries, Bolden, Nicholas, Zirbes, Christian F., Pamatmat, Anthony J., Boyken, Linda, Hill, Jared J., Bartels, Alyssa R., Thurman, Andrew L., Reeb, Valerie C., Porterfield, Harry S., Moustafa, Ahmed M., Planet, Paul J., Fischer, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581212/ https://www.ncbi.nlm.nih.gov/pubmed/37724867 http://dx.doi.org/10.1128/spectrum.02084-23 |
Ejemplares similares
-
Parallel Evolution of Linezolid Resistant Staphylococcus aureus in Patients with Cystic Fibrosis
por: Pitcher, Nicholas J., et al.
Publicado: (2023) -
418: Linezolid-resistant Staphylococcus aureus in patients with cystic fibrosis
por: Pitcher, N., et al.
Publicado: (2021) -
Safety and Outcomes of Linezolid Use for Nocardiosis
por: Davidson, Natalie, et al.
Publicado: (2020) -
Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung
por: Planet, Paul J
Publicado: (2022) -
464. Rapid whole genome sequence typing reveals multiple waves of SARS-CoV-2 spread
por: Moustafa, Ahmed M, et al.
Publicado: (2020)